MoonLake Immunotherapeuti... (MLTX)
NASDAQ: MLTX
· Real-Time Price · USD
54.42
-0.46 (-0.84%)
At close: Aug 15, 2025, 3:59 PM
54.39
-0.06%
After-hours: Aug 15, 2025, 04:20 PM EDT
MoonLake Immunotherapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -179.91M | -148.13M | -121.24M | -82.29M | -57M | -45.08M | -43.63M | -52.66M | -55.78M | -60.84M | -64.51M | -50.26M | -41.81M | -57.08M | -41.27M | -39.05M | -32.76M | -76.29K |
Depreciation & Amortization | 2.45M | 1.74M | 1.38M | 86.73K | 57.5K | 32.68K | 13.16K | 13.16K | 13.16K | 13.16K | 12.36K | 12.55K | 11.53K | 8.24K | 5.75K | 2.27K | n/a | n/a |
Stock-Based Compensation | 9.38M | 7.89M | 7.28M | 6.95M | 6.54M | 6.21M | 7.11M | 8.1M | 9.26M | 10.24M | 9.65M | 14.82M | 14.09M | 12.85M | 10.86M | 3.11M | 1.25M | n/a |
Other Working Capital | 5.33M | 185.1K | -2M | -4.73M | -12.64M | -8.51M | -5.38M | 2.56M | 4.2M | -701.85K | 486.98K | -1.2M | -1.85M | 4.07M | 2.14M | 2.08M | -13.69K | -13.69K |
Other Non-Cash Items | -2.23M | 2.21M | 4.12M | 5.51M | 3.88M | 1.94M | -50.81K | 115.56K | 212.44K | 336.06K | 372.49K | 219.93K | 325.66K | 31.67M | 31.57M | 31.57M | 31.42M | -17.82K |
Deferred Income Tax | n/a | n/a | n/a | 37.47K | 13.51K | n/a | n/a | -37.47K | -13.51K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 3.9M | -1.43M | -3.9M | -6.54M | -13.69M | -9.63M | -6.22M | 2.44M | 4.18M | -479.78K | -1.43M | -1.69M | -2.18M | 3.74M | 4.1M | 2.24M | -13.69K | -13.69K |
Operating Cash Flow | -166.42M | -139.78M | -116.59M | -80.46M | -64.43M | -48.7M | -42.78M | -42.03M | -42.13M | -50.73M | -55.89M | -44.66M | -37.33M | -16.56M | -2.48M | -2.12M | -101.66K | -107.8K |
Capital Expenditures | -342.76K | -342.75K | -519.52K | -628.59K | -496.4K | -496.4K | -284.63K | n/a | n/a | -16.01K | -32.02K | -60.54K | -72.19K | -56.18K | -40.17K | -11.65K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -382.33M | -351.11M | -350.28M | -175.76B | -175.91B | -175.82B | -175.73B | -175.73M | -42.23M | -42.23M | -42.23M | -42.23M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 438.13M | 230.91M | 145.2M | 262.57M | 176.33M | 190.31M | 150.83M | 33.68M | 32.32M | 19.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 3.00 | -87.74M | -116.34M | 175.44B | 175.44B | 175.53B | 175.56B | 9.76M | 9.89M | 9.89M | 9.88M | -26.22K | 16.01K | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 55.45M | -120.55M | -205.6M | 58.6M | -174.06M | -73.64M | -25.18M | -132.15M | n/a | -12.68M | -32.34M | -42.27M | -56.18K | -56.18K | -40.17K | -11.65K | n/a | n/a |
Debt Repayment | 73.02M | 73.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15M | 15M | 15M | 15M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | -50 | -50 | -50 | -50 | n/a | n/a | n/a | n/a | n/a | -7.44K | -7.44K | -7.44K | -7.44K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 52.78M | 52.78M | 51.22M | -4.22M | -4.32M | -4.32M | -2.75M | 3.79K | 3.79K | 104.69M | 104.69M | 104.14M | 104.14M | -541.88K | -603.73K | -54.78K | -58.06K | -58.06K |
Financial Cash Flow | 73.46M | 73.46M | 51.31M | 79.58M | 79.39M | 530.68M | 479.7M | 451.29M | 451.29M | 104.69M | 119.69M | 143.34M | 143.84M | 39.15M | 24.09M | 440.27K | -58.06K | -58.06K |
Net Cash Flow | -36.11M | -186.87M | -270.74M | 57.49M | -159M | 408.31M | 411.66M | 276.96M | 409.08M | 41.3M | 31.47M | 32.8M | 82.77M | -1.09M | -2.05M | -1.69M | -159.72K | -165.86K |
Free Cash Flow | -166.76M | -140.12M | -117.11M | -81.09M | -64.93M | -49.2M | -43.06M | -42.03M | -42.13M | -50.75M | -55.93M | -44.72M | -37.4M | -16.62M | -2.52M | -2.13M | -101.66K | -107.8K |